LEAD Therapeutics raises $17 million in Series A financing

News | 11. 05. 2007

LEAD Therapeutics

LEAD Therapeutics, Inc., a chemistry-driven drug discovery company, today announced it has raised $17 million in Series A financing co-led by Pappas Ventures and ProQuest Investments. Also participating in this financing round is Mustang Ventures, a China-focused venture firm.